Releaf has joined forces with SOMAÍ Pharmaceuticals in an exclusive partnership to grant Releaf patients access to SOMAÍ's Indica Essentials product line and its mint-flavored range.
Tim Kirby, Chief Executive Officer at Releaf said: "Since launching Releaf in February 2024 after 2 years of planning and investment, it has been so important for Releaf to form deep, strategic alliances with providers aligned with our values. SOMAÍ ticked all our boxes; long-term ambition, quality products, innovation paths that are healthcare-focused, and quality of life improvement for patients, to name but a few."
For more information:
Somai Pharmaceuticals
www.somaipharma.eu